Tested after gastric bypass for low blood sugar
Treatments studied
Part of Hormones & metabolism clinical trials.
This early study looks at a gut hormone–based treatment (GLP-1) and how it affects blood sugar and digestion after gastric bypass. It may help people who are having repeated low blood sugar episodes after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Have had gastric bypass surgery
- Have repeated episodes of low blood sugar after your gastric bypass
- Do not have active serious organ problems or major ongoing illnesses
- Be able to have the study tests as a generally healthy person (not currently very unwell)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early trial studies how blood sugar moves in people after certain weight-loss surgery compared with people without surgery. It may help researchers understand why blood sugar can drop too low and how treatments like atropine affect that process.
This early-phase study looks at how the body’s hormone signals and nerve control affect insulin release after gastric bypass surgery. It may help researchers understand what drives low blood sugar and how to better monitor or treat it.
This study looks at how the hormone glucagon affects blood sugar in people who have had gastric bypass or sleeve gastrectomy surgery more than a year ago, compared to people who have not had any gastrointestinal surgery. It aims to understand glucose metabolism better and may help improve care for people after bariatric surgery.
This trial tests whether a new way of using glucose monitoring can help manage low blood sugar that happens after meals in people who have had gastric bypass surgery. It aims to find better ways to track and treat these episodes.
This study looks at how a hormone called GLP-1, made in the pancreas, affects blood sugar levels in people with borderline high blood sugar (prediabetes). It may help find new ways to prevent diabetes.
This study tests a medication called mizagliflozin to help people who have low blood sugar after gastric bypass surgery. It may reduce the number of low blood sugar episodes and improve symptoms.
Hear when a new Post-bariatric Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.